Subscribe to our Newsletters !!
Bovine Serum Albumin (BSA) is an important reagent
hen it comes to drug development, optimizing formu
Sepsis is an overly amplified response of the body
Husky Technologies™ is excited to announce a maj
Alembic Pharmaceuticals Limited (Alembic) today an
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Micr
Roche Holding AG’s risdiplam showed significant improvement in survival and motor milestones in a clinical trial for infants with type 1 spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday.
Location of neurons affected by spinal muscular atrophy in the spinal cord
The Firefish part 2 study met its primary endpoint by demonstrating a significant increase in motor milestones in infants aged 1-7 months after 12 months of treatment, it said. Safety was consistent with the safety profile observed to date and no new safety signals were identified, it added.
